About this Journal Submit a Manuscript Table of Contents
Mediators of Inflammation
Volume 2013 (2013), Article ID 479739, 8 pages
http://dx.doi.org/10.1155/2013/479739
Research Article

Resistin Regulates Pituitary Lipid Metabolism and Inflammation In Vivo and In Vitro

1Department of Physiology, School of Medicine, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
2CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Spain
3Endocrinology and Nutrition Service, Carlos Hayà Hospital, Fundación IMABIS, 29009 Málaga, Spain
4CIBER Diabetes and Metabolic Illness (CIBER-DEM), Spain
5Department of Cellular Biology, Physiology and Inmunology, School of Siences, University of Córdoba, Córdoba, Spain

Received 28 December 2012; Revised 21 March 2013; Accepted 21 March 2013

Academic Editor: Fabrizio Montecucco

Copyright © 2013 F. Rodriguez-Pacheco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Zhang, B. Chai, J. Y. Li, H. Wang, and M. W. Mulholland, “Effect of des-acyl ghrelin on adiposity and glucose metabolism,” Endocrinology, vol. 149, no. 9, pp. 4710–4716, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Kovacs, R. D. Kineman, A. V. Schally, M. Zarandi, K. Groot, and L. A. Frohman, “Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly,” Endocrinology, vol. 138, no. 11, pp. 4536–4542, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Cordoba-Chacon, M. D. Gahete, J. P. Castano, R. D. Kineman, and R. M. Luque, “Homologous and heterologous in vitro regulation of pituitary receptors for somatostatin, growth hormone (GH)-releasing hormone, and ghrelin in a nonhuman primate (Papio anubis),” Endocrinology, vol. 153, no. 1, pp. 264–272, 2012. View at Publisher · View at Google Scholar
  4. W. J. Brown, L. Williams, J. H. Ford, K. Ball, and A. J. Dobson, “Identifying the energy gap: magnitude and determinants of 5-year weight gain in midage women,” Obesity, vol. 13, no. 8, pp. 1431–1441, 2005.
  5. K. Wynne, S. Stanley, B. McGowan, and S. R. Bloom, “Appetite control,” Journal of Endocrinology, vol. 184, no. 2, pp. 291–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Verdich, A. Flint, J. P. Gutzwiller et al., “A meta-analysis of the effect of glucagon-like peptide-1 (7–36) amide on Ad Libitum energy intake in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 9, pp. 4382–4389, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Mojsov, G. C. Weir, and J. F. Habener, “Insulinotropin: glucagon-like peptide I (7–37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas,” Journal of Clinical Investigation, vol. 79, no. 2, pp. 616–619, 1987. View at Scopus
  8. M. A. Nauck, M. M. Heimesaat, C. Orskov, J. J. Holst, R. Ebert, and W. Creutzfeldt, “Preserved incretin activity of glucagon-like peptide 1 [7–36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus,” Journal of Clinical Investigation, vol. 91, no. 1, pp. 301–307, 1993. View at Scopus
  9. V. Matheeussen, L. Baerts, G. de Meyer et al., “Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries,” Biological Chemistry, vol. 392, no. 3, pp. 189–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Nauck, E. Bartels, C. Orskov, R. Ebert, and W. Creutzfeldt, “Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7–36) amide infused at near-physiological insulinotropic hormone and glucose concentrations,” Journal of Clinical Endocrinology and Metabolism, vol. 76, no. 4, pp. 912–917, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. D. J. Drucker, J. Philippe, S. Mojsov, W. L. Chick, and J. F. Habener, “Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 10, pp. 3434–3438, 1987. View at Scopus
  12. L. L. Kjems, J. J. Holst, A. Vølund, and S. Madsbad, “The influence of GLP-1 on glucose-stimulated insulin secretion: Effects on β-cell sensitivity in type 2 and nondiabetic subjects,” Diabetes, vol. 52, no. 2, pp. 380–386, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Mentis, I. Vardarli, L. D. Köthe et al., “GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes,” Diabetes, vol. 60, no. 4, pp. 1270–1276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Dalamaga, G. Sotiropoulos, K. Karmaniolas, N. Pelekanos, E. Papadavid, and A. Lekka, “Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters,” Clinical Biochemistry, 2013. View at Publisher · View at Google Scholar
  15. J. J. Holst and C. F. Deacon, “Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors,” Diabetologia, vol. 48, no. 4, pp. 612–615, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. B. Toft-Nielsen, M. B. Damholt, S. Madsbad et al., “Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 8, pp. 3717–3723, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Reichlin, “Growth hormone content of pituitaries from rats with hypothalamic lesions,” Endocrinology, vol. 69, pp. 225–230, 1961. View at Scopus
  18. R. Guillemin, P. Brazeau, P. Bohlen, F. Esch, N. Ling, and W. B. Wehrenberg, “Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly,” Science, vol. 218, no. 4572, pp. 585–587, 1982. View at Scopus
  19. L. T. O. Lee, F. K. Y. Siu, J. K. V. Tam et al., “Discovery of growth hormone-releasing hormones and receptors in nonmammalian vertebrates,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 7, pp. 2133–2138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Berry, C. H. Srivastava, L. R. Rubin, W. R. Phipps, and O. H. Pescovitz, “Growth hormone-releasing hormone-like messenger ribonucleic acid and immunoreactive peptide are present in human testis and placenta,” Journal of Clinical Endocrinology and Metabolism, vol. 75, no. 1, pp. 281–284, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Tomas, T. S. Tsao, A. K. Saha et al., “Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 16309–16313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Tomas, T. S. Tsao, A. K. Saha et al., “Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 16309–16313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Zakikhani, R. Dowling, I. G. Fantus, N. Sonenberg, and M. Pollak, “Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells,” Cancer Research, vol. 66, no. 21, pp. 10269–10273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Ciampani, A. Fabbri, A. Isidori, and M. L. Dufau, “Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function,” Endocrinology, vol. 131, no. 6, pp. 2785–2792, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Matsubara, M. Sato, M. Mizobuchi, M. Niimi, and J. Takahara, “Differential gene expression of growth hormone (GH)-releasing hormone (GRH) and GRH receptor in various rat tissues,” Endocrinology, vol. 136, no. 9, pp. 4147–4150, 1995. View at Scopus
  26. H. Kiaris, M. Koutsilieris, A. Kalofoutis, and A. V. Schally, “Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists,” Expert Opinion on Investigational Drugs, vol. 12, no. 8, pp. 1385–1394, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Bagnato, C. Moretti, J. Ohnishi, G. Frajese, and K. J. Catt, “Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary,” Endocrinology, vol. 130, no. 3, pp. 1097–1102, 1992. View at Publisher · View at Google Scholar · View at Scopus
  28. C. T. Lim, B. Kola, and M. Korbonits, “AMPK as a mediator of hormonal signalling,” Journal of Molecular Endocrinology, vol. 44, no. 2, pp. 87–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. W. W. Winder and D. G. Hardie, “Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise,” The American Journal of Physiology, vol. 270, no. 2, pp. E299–E304, 1996. View at Scopus
  30. M. C. Towler and D. G. Hardie, “AMP-activated protein kinase in metabolic control and insulin signaling,” Circulation Research, vol. 100, no. 3, pp. 328–341, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. G. R. Steinberg and S. B. Jørgensen, “The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity,” Mini Reviews in Medicinal Chemistry, vol. 7, no. 5, pp. 519–526, 2007. View at Scopus
  32. V. Locatelli and A. Torsello, “Pyruvate and satiety: can we fool the brain?” Endocrinology, vol. 146, no. 1, pp. 1–2, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Motoshima, B. J. Goldstein, M. Igata, and E. Araki, “AMPK and cell proliferation—AMPK as a therapeutic target for atherosclerosis and cancer,” Journal of Physiology, vol. 574, no. 1, pp. 63–71, 2006. View at Publisher · View at Google Scholar · View at Scopus